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1. Summary 
 
In the 1980s a model of adaptive and pathologic responses to acute and chronic hypoxia was 
described in which Madison (M) rats had pathologic response to acute hypoxia (development 
of i.e. pulmonary edema) and adaptive responses to chronic hypoxia, where as in contrast, 
Hilltop (H) rats adapted well to acute but not chronic hypoxia (development of pulmonary 
edema and hypertension as well as widespread vascular remodelling). The transcription factor 
Hypoxia-inducible factor-1 (HIF-1) has been extensively investigated and its role as a 
protective factor has been clearly established. Also, it was indicated that M rats had lower 
HIF-1 activity compared to H rats under hypoxia.  
Thus, we utilized this model to hypothesize that protection from acute hypoxia was associated 
with elevated HIF-1 activity whereas a prolonged HIF-1 activation would lead to a pathologic 
response. Cardiopulmonary hemodynamics, blood gasses, right ventricular hypertrophy and 
pulmonary leak, vascular remodelling, HIF-1 DNA- binding and plasma Epo and VEGF were 
determined in these animals under acute (24h) or chronic (21d) hypoxic (18,000ft/5500m) or 
normoxic conditions. Pulmonary HIF-1 DNA-binding activity was unchanged in acute and 
chronic hypoxia-exposed M rats, but elevated in H rats.  
We conclude that pulmonary HIF-1 DNA-binding activity is associated with protection from 
acute hypoxia, while prolonged activity is associated with pathologic response to chronic 
hypoxia.  
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2.  Zusammenfassung 
 
In den 1980er Jahren wurde ein Modell von adaptiven und pathologischen Antworten auf 
akute  und chronische Hypoxie beschrieben, in welchem Madison (M) Ratten pathologisch 
auf akute Hypoxie reagierten (Entwicklung eines Lungenödems) und adaptive Mechanismen 
bei chronischer Hypoxie zeigten, während Hilltop (H) Ratten sich gut an akute, jedoch nicht 
an chronische Hypoxie adaptierten (Entwicklung eines Lungenödems, Hypertension, 
vaskulärer Umbau der Lunge). Hypoxie-induzierter Faktor-1 (HIF-1) wurde bereits intensiv 
erforscht und seine Rolle als protektiver Faktor klar aufgezeigt. Ebenso zeigten M Ratten 
unter Hypoxie eine geringere HIF-1 Aktivität als H Ratten. 
Deshalb benutzten wir diese Modell um die Hypothese aufzustellen, dass eine gesteigerte 
pulmonäre HIF-1 Aktivität kurzfristig ein Schutz vor Hypoxie bietet, langfristig aber 
pathologische Folgen hat. Die beiden Rattenstämme wurden akuter (24 Stunden) oder 
chronischer (21 Tage) Hypoxie (18,000 Fuss/5500m) oder Normoxie ausgesetzt und 
anschliessend wurden kardiovaskuläre hämodynamische Messungen durchgeführt und 
Blutgase gemessen,  auf Rechtsherzhypertrophie, Lungenödem und vaskulärer Umbau der 
Lunge geachtet und HIF-1 DNA-Bindung und Plasma Epo und VEGF gemessen.  
Die aufgestellte Hypothese wurde klar von unseren Ergebnissen belegt, HIF-1 schützt vor 
akuter Hypoxie, eine langfristige gesteigerte Aktivität hat jedoch pathologische 
Konsequenzen. 
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3. Introduction 
 
Response to acute or chronic hypoxia can be adaptive or pathologic. Over the past 20 years 
there has been an explosion of research into the effects of hypoxia on the organism, cells, 
organelles, and molecules, which has greatly enhanced our understanding of hypoxic 
responses. However, the majority of research has focused on responses of ‘normal’, healthy 
animals or cells, largely because it is not feasible to study humans with pathologic responses 
to hypoxia at a molecular level. 
In the early 1980s, just prior to the recognition of the importance of hypoxia in many diseases, 
Ou and colleagues identified two rat strains, which presented divergent responses to acute and 
chronic hypoxia (18, 20). Subsequent studies provided an intriguing story of one rat strain 
(Madison rats) that developed pulmonary edema in response to acute exposure (24h) to 
hypoxia (18,000 ft above sea level). Unexpectedly, another strain (Hilltop rats) developed 
pulmonary edema, severe pulmonary hypertension and pulmonary vascular remodelling in 
response to chronic exposure to hypoxia (18,000 ft for 21 days) (17-20, 25). In contrast, these 
Hilltop rats did not develop pulmonary edema in response to acute hypoxia and Madison rats 
did not develop pulmonary edema in response to chronic hypoxia and had only mild increases 
in pulmonary artery pressure.  Following the discovery of hypoxia-inducible transcription 
factor-1 (HIF-1), believed to be the long sought oxygen sensor, we (7) decided to re-
investigate these models, hypothesizing that HIF-1 activation would be greater in Hilltop 
compared with Madison rats exposed to acute hypoxia. Indeed, data revealed that there was 
greater pulmonary HIF-1 activity in the more adapted Hilltop strain than in the edemic 
Madison strain, leading our old group to speculate that HIF-1 was protective in response to 
acute hypoxia in this model. 
Subsequent research provided evidence that prolonged HIF-1 activity may actually lead to 
pathologic responses to hypoxia (9, 14, 26). This observation led us to hypothesize that HIF-1 
activity may remain elevated during chronic hypoxia in Hilltop rats, but not Madison rats. 
Chronically elevated HIF-1 activity would be associated with greater pulmonary edema, 
hypertension and remodelling in Hilltop rats in comparison to Madison rats.  
In approaching this research, we discovered the origin of the Hilltop rat strain was in question 
and it was unclear weather the obtained strain was the same as used in previous studies. 
Therefore, our initial approach was to verify the validity of the model by exposing Madison 
and Hilltop rats to acute (24h) and chronic (21d) hypoxia (18,000 ft/5500 m) and evaluating 
cardiovascular and pulmonary hemodynamics, and blood gases in response to acute and 
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chronic hypoxia. Hypoxic responses were then evaluated by determining the presence or 
absence of pulmonary hypertension, edema and vascular remodelling, and right ventricular 
hypertrophy. Finally, HIF-1 activation was determined by analysing HIF-1 DNA-binding in 
the lungs and the concentration of HIF-mediated plasma proteins Epo and VEGF. 
 
 
 
 
Keywords: adaptation to high altitude, pulmonary edema, pulmonary vascular remodelling, 
                   hypoxia-inducible transcription factor, reduced oxygenation 
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!4. Materials and Methods !
Animals 
Male Madison Sprague-Dawley (Barrier 217) and Hilltop rats (280–350 g and 10–12 wk of 
age) were obtained from commercial vendors (Harlan, Indianapolis, IN and Hilltop Rats, Inc., 
Scottsdale, PA). Animals were allowed ad libitum access to food and water, and kept on a 12-
hour day–night cycle. All experimental protocols were reviewed and approved by the 
Institutional Animal Care and Use Committee at the University of Colorado, Denver, 
Anschutz Medical Campus.  
 
Experimental Protocol 
Animals from each rat strain, Madison (M) and Hilltop (H), were randomly assigned to 24 h 
or 21 d, normoxic or hypoxic conditions (n=40 total animals, n=5 per group), see Table 1. 18 
% oxygen refers to the oxygen content in ambient Denver air. 
 
Chronic Instrumentation 
To allow measurement of cardiovascular and pulmonary parameters without the 
complications of anesthesia, animals in the 24 h protocol were chronically instrumented 48 h 
prior to implementation of the experimental protocol, as described below. Because catheter 
patency was unreliable 21 d following instrumentation, cardiovascular and pulmonary 
parameters were assessed in anesthetized animals under normoxic conditions. Hypothesized 
changes in response to chronic hypoxia such as pulmonary vascular remodelling and 
hypertension should be evident despite anesthetic conditions. 
Rats were allowed to acclimate to ambient altitude for at least seven days prior to 
instrumentation. Forty-eight hours prior to surgery, rats were provided water supplemented 
with acetaminophen/codeine (0.5 mg/ml and 0.05 mg/ml, respectively) for postoperative 
analgesia. The animals were weighed and hematocrits were determined. Rats were 
anesthetized with a mixture of ketamine: Rompon (xylazine) (75 mg/kg: 6 mg/kg I.P.). Under 
aseptic conditions, the left carotid artery was cannulated with a PE-50 (0.58 mm ID; Becton 
Dickinson) catheter. A PV 1 (0.28 mm ID, Becton Dickinson) catheter with a shallow bend at 
its tip was inserted into the right ventricle via the right jugular vein and guided into the main 
pulmonary artery. 
Pressure tracings confirmed placement in the pulmonary artery. Next, two PE-50 (0.58 mm 
ID, Becton Dickinson) catheters were placed in the superior vena cava via the right jugular 
vein for venous blood collection and to obtain cardiac output values. All catheters were 
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flushed with heparinized saline, tied off, tunnelled subcutaneously to the dorsal neck region, 
and exteriorized at the back of the neck. Animals were allowed at least 48 h to recover prior 
to any treatments. Animals demonstrating signs of infection, diarrhoea, or distress were 
excluded from study. As discussed above, animals exposed to 21 d hypoxia were 
anesthetized, catheterized as described above and cardiovascular pulmonary parameters 
measured under anaesthesia. 
 
Hypoxic Exposure 
Animals assigned to the chronic hypoxia groups were exposed to a simulated high altitude: 
5,500 m (18,000 ft), barometric pressure - 380 mmHg in a specially designed rodent 
hypobaric chamber facility as previously described (4, 15).  
 
Hemodynamic Measurements 
Animals in the 24 h protocol were placed in a custom designed, small, rectangular, Plexiglas 
chambers with a portal through which catheters could be passed. Hypoxia was achieved by 
flushing the chamber with 10% O2 gas (equivalent to 5500 m altitude) and ambient altitude 
was achieved by allowing room air to circulate in the chamber. Catheters were flushed with 
heparinized saline and then connected to fluid filled pressure transducers. Systemic blood 
pressure, pulmonary artery blood pressure, heart rate, cardiac output and blood gases were 
determined for 10 min under experimental conditions for each animal (normoxia, hypoxia or 
during anaesthesia in the animals exposed for 21 d). Cardiac output was measured by infusion 
of Cardiogreen (Sigma Aldrich, St. Louis, MO) dye and a specially designed densitometer 
and software (Deterministic systems, Boulder, CO) to detect and calculate cardiac output 
from the dye dilution. Cardiac output was normalized to body weight and reported as cardiac 
index.  
 
Blood gases and co-oximetry measurements 
Blood samples were collected immediately after hemodynamic measurements had been 
obtained. Arterial blood (0.2 ml) was withdrawn via carotid catheter into blood gas syringes, 
at which point blood gasses were analysed via ABL5, Radiometer, Copenhagen and co-
oximetry via OSM3, Radiometer, Copenhagen, with algorithms specific to rat haemoglobin.  
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Organ collection and tissue fixation 
The left bronchus was cannulated and the left lung fixed with 10% buffered formalin (3 ml) 
by airway inflation under constant pressure at 25 cm H2O pressure, after which the heart and 
lungs were removed en bloc. The hearts were removed and the atria were dissected from 
ventricles. The right ventricle (RV) and left ventricle plus septum (LV+S) were weighed for 
assessment of right ventricular hypertrophy (RV/LV+S ratio). Kidneys were placed 
immediately into 10% formalin. After 18 h the lungs and kidneys were removed from 10% 
formalin and placed in 70% ethanol, paraffin-embedded sectioned to 2 µm for 
immunohistochemical and morphometric analyses. 
 
Lung histology 
After acute or chronic normoxia or hypoxia animals were euthanized and the organs collected. 
For hypoxic animals this was done inside an air controlled chamber to prevent reoxygenation. 
Lungs were fixed in 10% buffered formalin, embedded in paraffin and cut in 2-3 µm sections 
and stained with hematoxylin and eosin (H&E). Additionally immunohistochemistry was 
done with the primary alpha smooth muscle actin (αSMA), a pre-diluted monoclonal mouse 
antibody (DAKO, Glostrup, Denmark, N1584). In brief, lung sections were incubated with 
this primary antibody (30 min, RT), rinsed with TBS (DAKO wash Buffer, S3006), and as 
secondary antibody labelled with peroxidase was used the detection kit ChemMate (3-Amino-
9-Ehtylcarbazol (AEC) from DAKO (K5003)). The slides were incubated with the second 
antibody (10 min, RT) and sections were counterstained with hematoxylin. A second set of 
sections was H&E-stained to evaluate oedema. 
 
Quantitative procedures 
Lung sections were analysed using StereoInvestigator software (MBF Bioscience, Williston, 
Vermont). The areas of the section were defined as regions of interest. Within this area, a 
uniform random systematic set of sampling locations was selected at 500 × 500 µm intervals 
along the x- and y- axis. At each sampling location, a 150 × 150 µm unbiased counting frame 
(11) was used to tally the intersections of blood vessels with the plane of the section. At the 
same time, vessels were classified as  non-, partially- or fully-muscularized (Figure 4). Within 
the area defined by the counting frame, the area fraction fractionator was used to estimate the 
volume of vascular smooth muscle and total vessel volume (without adventitia). The approach 
combines fractionator sampling with the Cavalieri estimator of volume (10). For the latter, we 
used a 10 × 10 µm point grid. 
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Media thickness is a commonly used parameter to describe changes in vessel structure. It is 
however difficult to provide replicable criteria for this measurement in view of the different 
extent of muscularization of the vessels and the different angles at which they penetrate the 
section. We therefore calculated media thickness based on estimates of media volume, non-
media volume and vessel length. Vessel length (L) was calculated from the number of 
intersection of vessels (Q, equivalent to the number of vessels counted multiplied by the area 
sampling fraction) section area (A) and the volume of the section (Vref): L = 2Q/A x Vref (10). 
Media thickness was calculated as the difference in the radius of a cylinder with total volume 
(media and non-media) and length L and the radius of a cylinder with non-media volume and 
length L. 
 
Pulmonary Vascular Protein Extravasation 
As previously described, pulmonary vascular leak was assessed by lung protein extravasation 
determined by the Evans blue dye method (16). Briefly, Evans blue dye (20 mg/kg) was 
injected via the venous catheter 15 minutes prior to euthanasia with an overdose of sodium 
pentobarbital (100 mg/kg) via the jugular catheter. Animals were then transcardially perfused 
with phosphate buffered saline. The left lung lobe was then perfused-fixed for 
immunohistochemical analyses (see below). The right lung lobe was then removed. After 
weighing, the caudal lobe was frozen in liquid nitrogen for extraction of Evan’s blue dye. At a 
later time, Evans blue dye was extracted from the caudal lobe by formamide (100%) 
incubation (24 h, 37°C). The medial lobe was immediately weighed, oven dried (65°C, 48 h), 
and weighed again. Wet weight: dry weight ratio in the medial lobe was used to estimate the 
dry weight of the caudal lobe. The extracted dye was quantified in a spectrophotometer by 
measuring the absorbance at 600 nm against standards of Evans blue dye dissolved in 
formamide. Evans blue dye extravasation is expressed as nanograms of Evan’s blue dye per 
milligram of dried tissue. 
 
Plasma Epo and VEGF 
Plasma, collected from heparinized whole blood, was analysed for erythropoietin (Epo) and 
vascular endothelial growth factor (VEGF) using ELISA methodology as previously 
described (R&D Systems, Minneapolis, MN, USA, Catalogue Numbers MEP00B and RRV00 
respectively) (31).  
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HIF-1alpha DNA-binding  
Nuclear protein from HPAEC was prepared using a Clontech TransFactor Extraction Kit 
(Palo Alto, CA, USA) and protein concentration was determined using a BCA protein assay 
kit (Pierce Biotechnology, Rockford, IL, USA). HIF-1 DNA-binding was then determined 
using the Clontech Transfactor Colorometric Kit (Palo Alto, CA, USA), as previously 
described (30). 
 
Statistics 
Statistical analysis and presentation follow the guidelines of the American Physiological 
Society (5). A two-way ANOVA (SPSS 19, IBM SPSS Statistics or GraphPad Prism 4) was 
used to evaluate strain and treatment differences and interactions between strain and 
treatment. P-values less than 0.05 were considered significant.  
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5. Results 
Blood gas analyses 
Acute hypoxia 
Blood gas values differed between strains; however the effect of hypoxia was obvious (Table 
2). The partial pressure of oxygen (pO2) (p<0.0001), oxygen saturation (SAT) (p<0.0001) and 
partial pressure of carbon dioxide (pCO2) (p<0.0001) were all significantly lower in hypoxia 
compared to normoxia. Furthermore, pH was increased (p=0.0002) in hypoxia compared to 
normoxia. 
Chronic hypoxia 
On the other hand, after 21 days of hypoxic exposure pO2 and pCO2 were normalized in both 
strains, but oxygen saturation in both strains was lower with hypoxia (p=0.002) and with H 
being significantly lower than M (p=0.04) (Table 3). pH values were lower after chronic 
hypoxia (p<0.0001) and again to a larger extent in H rats (p=0.017).  
 
Oxygen capacity 
Acute Hypoxia 
There was no effect of acute hypoxia on hemoglobin (Hb) and O2 capacity (O2cap), yet higher 
values were observed in hypoxic H compared with M rats (Hb p=0.032 / O2cap p=0.035) 
(Table 3). Reduced Hb was, as expected, higher under hypoxia (p<0.0001) in both strains, and 
hematocrit was unchanged.  
Chronic Hypoxia 
In contrast, Hb and O2 cap were elevated following chronic hypoxia in both strains with the 
greatest increase in H rats (Table 3). Similar findings were observed for reduced Hb and 
HCT; all were elevated with chronic hypoxia, yet hypoxic H rats had significantly greater 
values than M rats. 
 
Systemic pressures 
Acute Hypoxia 
There were no changes in systemic pressures in response to acute hypoxia (Table 2).  
Chronic Hypoxia 
After 21 days of hypoxia systemic diastolic pressure, total systemic resistance (TSR) and 
heart rate were not significantly different, whereas systemic mean pressure mean (p=0.029), 
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systemic systolic pressure (p=0.037) and cardiac output (p=0.042) were all lower than in 
normoxic conditions (Table 3). 
 
Pulmonary artery pressure 
Acute Hypoxia 
Once exposed to acute hypoxia, both rat strains showed elevated pulmonary artery pressure 
(Ppa) (p<0.0001), whereas the total pulmonary resistance (TPR) did not increase significantly 
(p=0.0847) (Figure 1).  
Chronic Hypoxia 
Chronic hypoxic exposure resulted in elevated PPA and TPR (p<0.0001), and PPA was 
significantly greater in hypoxic H as compared with M rats (p=0.0064 (Table 3).  
 
Right ventricular hypertrophy  
Acute Hypoxia 
Although PPA rose with acute hypoxia, the time of exposure was too short to allow for 
cardiac hypertrophy. 
Chronic Hypoxia 
In lieu of the fact that PPA and TPR were significantly elevated following chronic hypoxia, 
the finding of right ventricular (RV) hypertrophy was expected and observed in both strains 
(Figure 2).  
 
Pulmonary edema 
Acute Hypoxia 
Because acute hypoxia is associated with the development of pulmonary edema, associated 
with high pulmonary artery pressures, we assessed pulmonary leak using Evan’s blue dye. 
Pulmonary leak was detected in M but not in H rats after acute hypoxic exposure (Figure 3). 
Chronic Hypoxia 
However, after 21days of hypoxia, the findings were reversed, pulmonary leak was observed 
in H, but not in M rats. Histological evidence supported the findings from the Evan’s blue dye 
studies, elevated numbers of alveolar macrophages in the alveolar spaces, as compared with 
normoxic animals. Additional evidence of edema from histological studies included the 
presence of clear fluid in widened interstitium around bronchi, bronchioles, blood vessels and 
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interlobar septae. Furthermore, in chronic hypoxic H rats, signs of occlusion in small vessels 
and a few thrombi in larger vessels were detected.  
 
Pulmonary vascular remodelling in response to chronic hypoxia 
The acute hypoxia exposures were not of sufficient length to for pulmonary vascular 
remodelling to develop. Therefore, data were only collected from chronically hypoxic and 
normoxic animals. 
Rigorous stereological analyses of lung sections were conducted to determine the exact nature 
of hypoxic effects on the pulmonary vasculature (Figure 4, and Table 4). H rats had greater 
volume (p=0.001) and thickness (p<0.001) of vascular media than the Madison rats under 
normoxic conditions, but non-medial layers had similar characteristics (Table 4). In both 
strains, chronic hypoxia was associated with greater volume of the media (p<0.001) and t 
medial thickness (p<0.001), while non-medial layers were not affected (p=0.212). 
Vessel length in the sections was not different between the two strains (p=0.767) but differed 
for the treatments (p=0.017). Assessed areas of lung sections were not different between the 
two strains (p=0.203) or between the treatments (normoxia and hypoxia, p=0.072). 
Under normoxic conditions, a greater percent of pulmonary vessels in the H rat were fully-
muscularized (p<0.001) and a lesser percent non-muscularized (p=0.03), than in the M rats 
(Figure 5).  In response to chronic hypoxia, both a greater percent of vessels were fully-
muscularized and a lesser percent non-muscularized compared with normoxic values. 
Chronically hypoxic H rats had significantly more fully-muscularized vessels (p=0.017) than 
M animals.  
 
Plasma Epo and VEGF  
Plasma Epo and VEGF were evaluated because hypoxia is associated with elevations in 
plasma Epo and VEGF, and because Epo and VEGF have been implicated in elevations of 
pulmonary artery pressure and pulmonary vascular remodelling.   
Acute Hypoxia 
Acutely hypoxic H rats had significantly greater plasma Epo and VEGF than the normoxic H 
rats, however Epo and VEGF were not greater hypoxic as compared with normoxic M rats 
(Figure 6). 
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Chronic Hypoxia 
Chronically hypoxic H and M rats had greater Epo than normoxic rats, while only H rats had 
greater plasma VEGF. In fact, Epo and VEGF in chronically hypoxic H rats were even greater 
than that in hypoxic M rats. 
 
 
Pulmonary HIF-1alpha binding 
Because H and M rats showed distinct differences in pulmonary and hemodynamic responses 
to acute and chronic hypoxia which were further reflected in varying concentrations of 
associated factors plasma Epo and VEGF, analyses of the primary factor responsible for 
hypoxia-induced increases in Epo and VEGF, binding of hypoxia-inducible transcription 
factor -1 (HIF-1) to its DNA site was evaluated in the lungs. 
Acute Hypoxia 
HIF-1 DNA-binding in the nuclei of pulmonary cells was only elevated in H rats exposed to 
chronic hypoxia (Figure 6).  
Chronic Hypoxia 
After 21d of hypoxia, M rats showed no sign of elevated HIF-1 DNA-binding, yet chronically 
hypoxic H rats experienced very high levels of binding. 
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6. Discussion 
The data support previous findings of significantly divergent responses to acute and chronic 
hypoxia in Madison and Hilltop rats. Further investigation implicates hypoxia-inducible 
transcription factor -1 (HIF-1) in the variable physiologic responses between strains. 
Interestingly, differences in response to high altitude between diverse human populations 
have been attributed in part to EPAS1, the gene encoding HIF-2 (2, 29, 32). 
While some responses to hypoxia between the two strains are similar, such as equivalent 
decreases in PO2, PCO2, pH, or oxygen content associated with increases in pulmonary artery 
pressure (Ppa) in response to acute hypoxia, others are quite different, such as acute hypoxia 
only causing pulmonary edema in Madison rats and chronic hypoxia only causing pulmonary 
edema in Hilltop rats.  
Acute hypoxia 
In response to acute hypoxia, H and M rats had similar and expected decreases in PO2, PCO2, 
pH, Hb and oxygen content. They also had similar increases in hemoglobin and calculated 
oxygen capacity. Ppa was elevated in both strains, while TPR, cardiac output (CO), heart rate 
(HR) and systemic blood pressure remained unaltered. Despite all of these equivalent 
physiologic changes, only M rats developed pulmonary leak, H rats did not. On a molecular 
level, the apparent protection from acute hypoxia-induced pulmonary leak in H rats was 
associated with elevated plasma Epo, VEGF and pulmonary HIF-1 DNA-binding activity. In 
recent years, Epo has been implicated in many non-erythroid functions (8) including cellular 
protection from apoptosis (1, 23). Pulmonary leak involves apoptosis (22, 28), thus Epo may 
be contributing to the protection of the lungs from leak during hypoxia in H rats. Further, 
VEGF has been reported as possibly protective in high altitude pulmonary edema (12, 21). 
The higher HIF-1 activity in H as compared with M acutely hypoxic rats likely contributes to 
the elevated plasma Epo and VEGF. 
Chronic Hypoxia 
The chronic hypoxia blood chemistry data are collected under anesthesia due to the 
complications of maintaining patent catheters for 21 days. However, there were significant 
differences in blood chemistry between H and M rats exposed to chronic hypoxia. While PO2, 
PCO2 and oxygen content remained equivalent to that of normoxic animals, pH, O2 saturation, 
Hb were significantly lower in rats exposed to chronic hypoxia and HCT, Hb and oxygen 
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capacity increased compared to normoxic animals. Interestingly, hypoxic H rats had 
significantly lower pH and greater HCT, Hb than M rats, likely contributing to the large 
calculated oxygen capacity in chronically hypoxic H rats. 
Both strains demonstrated pulmonary hypertension following chronic hypoxia, yet H rats had 
much more dramatic mean pulmonary artery pressures, primarily due to a large increase in the 
systolic pressure, while total pulmonary resistance remained elevated to the same extent in 
both hypoxic strains. Of note, CO and HR remained unchanged. The pulmonary hypertension 
likely led to the development of right ventricular hypertrophy and accordingly the H strain, 
which had the greatest pulmonary artery pressures, had significantly more right ventricular 
hypertension.  
Unlike high altitude pulmonary edema, which occurs in humans shortly after arrival at high 
altitude, H rats only developed pulmonary leak after 21d at high altitude, not following acute 
hypoxia. These data do not address the mechanism of chronic hypoxia-induced pulmonary 
leak in H rats. However, the molecular data suggest a potential mechanism. Plasma Epo and 
VEGF, and pulmonary HIF-1 activity remained elevated following 21d hypoxia in H rats, 
however in M rats only plasma Epo remained elevated, yet in a significantly lower 
concentration than in H rats. The prolonged elevation of plasma Epo and VEGF, and 
pulmonary HIF-1 activity may contribute to the development of pulmonary leak. HIF-1 
activation and the resulting increase in expression of proteins such as Epo and VEGF are 
believed to protect the system from hypoxia, Epo by elevating erythropoiesis, VEGF by 
promoting angiogenesis (3), however prolonged elevation of HIF activity may have negative 
consequences such as pulmonary hypertension and remodelling (27). 
Pulmonary vascular remodelling  
As has been previously demonstrated (17, 20), H rats develop robust pulmonary hypertension 
and right ventricular hypertrophy in response to chronic hypoxia, which is associated with 
pulmonary vascular remodelling.  While the pulmonary vasculature of M rats had some 
evidence of remodelling in response to chronic hypoxia, it was much more pronounced in H 
rats. While previous studies have identified the extensive pulmonary remodelling in H rats 
exposed to chronic hypoxia, using the advantage of cutting edge stereologic methods, a more 
detailed investigation of the changes in pulmonary vessels was undertaken in the current 
study than was possible when the original study was conducted (17). 
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The initial finding was that the vascular medial layer, but not non-medial layers differed 
between the two strains and between normoxic and hypoxic animals. Normoxic H animals 
had a thicker medial layer than normoxic M animals, yet exposure to chronic hypoxia resulted 
in H and M rats have similar increases in media thickness and volume. Interestingly the 
percentage of all vessels that were fully-muscularized was greater in H as compared with M 
rats in normoxic control conditions, while the percent of non-muscularized vessels was less. 
Exposure to chronic hypoxia increased the percent of fully muscularized vessels in both 
strains, yet the largest increase was in H rats. 
HIF-1, Epo and VEGF have all been implicated in hypoxia-induced pulmonary vascular 
hypertension remodelling (6, 13, 24) and may well be playing a role in the extensive 
remodelling noted in the H as compared with M rats following chronic hypoxic exposure. 
Caveats 
Comparisons between acute and chronic data are difficult due the fact that animals in the 
acute study had patent catheters and data were collected awake animals, however it was not 
possible to keep catheters patent over 21days, thus animals were anesthetized during data 
collection. It was not possible to administer hypoxia during anesthesia; therefore all chronic 
data are collected during normoxia. Stereologic data should be interpreted as the result of 
chronic hypoxia, while blood gas values and HIF activity data must be interpreted as 
responses to normoxic anesthesia following exposure to chronic hypoxia.  
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Conclusion 
HIF-1 activity is associated with physiologic responses to acute hypoxia and pathophysiologic 
responses to chronic hypoxia in Hilltop rats. The highly variable physiologic responses to 
acute and chronic hypoxia between Madison and Hilltop rats are complex, yet may prove 
valuable to further understanding the divergent responses of individuals and ethnic groups to 
acute and chronic hypoxia. Indeed, very recent studies have revealed genetic determinants in 
Tibetans living at high altitude exist (reviewed in (29)), but the mechanisms that allow 
adaptation to high altitude remains unknown.   
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8. Figure legends !
Table 1. Male Madison Sprague-Dawley and Hilltop rats were randomly assigned to 24h or 
21d normoxic or hypoxic conditions (n=40 total animals, n=5 per group). Animals in the 21d 
experiments were catheterized at the completion of the exposure time and hemodynamic 
measurements were obtained under anesthesia (see materials and methods). 
Table 2. Blood gases, heart rate, systemic and pulmonary blood pressures, and cardiac output 
were determined for 10 min under experimental conditions in Madison and Hilltop rats (acute 
(24h) normoxia or hypoxia) *significantly different from normoxic value within same strain 
(p < 0.05), #significantly different from hypoxic value in different strain (p < 0.05). 
Table 3. Blood gases, heart rate, systemic and pulmonary blood pressures, and cardiac output 
were determined for 10 min under anesthesia in Madison and Hilltop following exposure to 
chronic (21d) normoxia or hypoxia. *significantly different from normoxic value within same 
strain (p < 0.05), #significantly different from hypoxic value in different strain (p < 0.05). 
Table 4: Media thickness for pulmonary vessels was calculated based on estimates of media 
vessel volume, non-media vessel volume and vessel length in Madison and Hilltop rats 
following exposure to chronic hypoxia. *significantly different from normoxic value within 
same strain (p < 0.05), #significantly different from hypoxic value in different strain (p < 
0.05). 
Figure 1: Pulmonary hemodynamics were measured after exposure to both, acute and chronic 
hypoxia. a) Systolic (white bars), diastolic (black bars) and mean (grey bars) pulmonary 
pressure after acute hypoxia, b) pulmonary pressures after chronic hypoxia and total 
pulmonary vascular resistance after c) acute, and d) chronic hypoxia. *significantly different 
from normoxic value within same strain (p < 0.05), #significantly different from hypoxic 
value in different strain (p < 0.05). 
Figure 2:  Right ventricular hypertrophy was determined by the ratio of right ventricle (RV) 
and left ventricle plus septum (LV+S) in Madison and Hilltop rats exposed to chronic 
hypoxia. *significantly different from normoxic value within same strain (p < 0.05), 
#significantly different from hypoxic value in different strain (p < 0.05). 
Figure 3: a) Evan’s Blue dye was employed to determine the presence of pulmonary edema 
following exposure to acute or chronic hypoxia (and normoxic controls) in Madison and 
Hilltop rats. b) Lung sections stained with hematoxylin and eosin (H&E) were analysed for 
the presence of edemic fluid. *significantly different from normoxic value within same strain 
(p < 0.05), #significantly different from hypoxic value in different strain (p < 0.0001). 
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Figure 4: a) Following chronic hypoxia, pulmonary vascular remodelling was assessed using 
immunohistochemical methods to identify smooth muscle cells in Madison and Hilltop rats. 
b) Quantitative analyses were performed using StereoInvestigateor software (MBF 
Bioscience, Williston, Vermont). *significantly different than all other values (p < 0.05). 
Figure 5: Immunohistochemistry was used to identify pulmonary vascular smooth muscle 
cells following chronic hypoxia in Madison and Hilltop rats. a) non-muscularized b) partially-
muscularized and c) fully-muscularized vessels. d) Quantitative analyses were performed 
using StereoInvestigateor software (MBF Bioscience, Williston, Vermont). *significantly 
different from normoxic value within same strain (p < 0.05), #significantly different from 
hypoxic value in different strain (p < 0.05). 
Figure 6: a) Plasma concentrations of erythropoietin (Epo), b) vascular endothelial growth 
factor (VEGF) in M and H rats were determined following exposure to acute or chronic 
hypoxia (normoxic controls) and c) nuclear proteins extracted from whole lung tissue were 
analysed for HIF-1 DNA-binding using the Clontech Transfactor Colorimetric kit in H and M 
rats exposed to acute or chronic hypoxia (normoxic controls). *significantly different from 
normoxic value within same strain (p < 0.05), #significantly different from corresponding 
value in different strain (p < 0.05), +significantly different from acute hypoxic value within 
same strain (p < 0.05). 
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